How is the value proposition driving the development and reimbursement process in major markets?
What are the strategies and practical steps companies can take in development?
2-3 December 2014, Vancouver, Canada
This workshop focused on how companies need to be able to integrate their target stakeholders’ different perspectives of value into their development decisions as well as using these insights to construct a viable value proposition to meet the needs of diverse stakeholders.
Workshop objectives
- Identify the key elements and the evidentiary requirements of a robust value proposition in order to build it into the early drug development phase
- Discuss the key barriers for building the value proposition early into the development of new medicines and discuss the best approaches to address these challenges, including how, when and which stakeholders (health technology assessors, payers, clinicians and patients) need to be engaged
- Consider how companies can more effectively use the value proposition to drive their development strategies and address reimbursement challenges
- Recommend approaches for the development, evaluation and utilisation of value propositions in the era of value-driven healthcare systems